Search research articles
Contact Us
Filters
Showing results (11-20 of 157) with videos related to
Page
of 16
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
April 16, 2004
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)
Gregory A Otterson, James E Herndon, Dorothy Watson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2002
Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer
Richard L Schilsky, Donna Bertucci, Nicholas J Vogelzang, et al.
Journal of Medical Imaging (Bellingham, Wash.)
|
December 13, 2024
Radiomics for differentiation of somatic <i>BAP1</i> mutation on CT scans of patients with pleural mesothelioma
Mena Shenouda, Abbas Shaikh, Ilana Deutsch, et al.
Investigational New Drugs
|
May 4, 2004
9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium
Hedy L Kindler, Anjali Avadhani, Kurombi Wade-Oliver, et al.
Journal of Pain and Symptom Management
|
November 23, 2011
Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303)
Dorothy Romanus, Hedy L Kindler, Laura Archer, et al.
The Annals of Thoracic Surgery
|
August 31, 2015
Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma Is an Effective and Safe Cytoreductive Surgery in the Elderly
Trevor Williams, Hadi Duraid, Sydeaka Watson, et al.
Academic Radiology
|
September 24, 2005
Evaluation of semiautomated measurements of mesothelioma tumor thickness on CT scans
Samuel G Armato, Geoffrey R Oxnard, Masha Kocherginsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2004
Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors
Manisha H Shah, Donn Young, Hedy L Kindler, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
January 24, 2016
Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma
Diana Y Kircheva, Aliya N Husain, Sydeaka Watson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 13, 2012
Optimization of response classification criteria for patients with malignant pleural mesothelioma
Zacariah E Labby, Samuel G Armato, Hedy L Kindler, et al.
Page
of 16
Search research articles
Search
Showing results (11-20 of 157) with videos related to
Sort By:
Page
of 16
Lung Cancer (Amsterdam, Netherlands)
|
April 16, 2004
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)
Gregory A Otterson, James E Herndon, Dorothy Watson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2002
Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer
Richard L Schilsky, Donna Bertucci, Nicholas J Vogelzang, et al.
Journal of Medical Imaging (Bellingham, Wash.)
|
December 13, 2024
Radiomics for differentiation of somatic <i>BAP1</i> mutation on CT scans of patients with pleural mesothelioma
Mena Shenouda, Abbas Shaikh, Ilana Deutsch, et al.
Investigational New Drugs
|
May 4, 2004
9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium
Hedy L Kindler, Anjali Avadhani, Kurombi Wade-Oliver, et al.
Journal of Pain and Symptom Management
|
November 23, 2011
Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303)
Dorothy Romanus, Hedy L Kindler, Laura Archer, et al.
The Annals of Thoracic Surgery
|
August 31, 2015
Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma Is an Effective and Safe Cytoreductive Surgery in the Elderly
Trevor Williams, Hadi Duraid, Sydeaka Watson, et al.
Academic Radiology
|
September 24, 2005
Evaluation of semiautomated measurements of mesothelioma tumor thickness on CT scans
Samuel G Armato, Geoffrey R Oxnard, Masha Kocherginsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2004
Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors
Manisha H Shah, Donn Young, Hedy L Kindler, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
January 24, 2016
Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma
Diana Y Kircheva, Aliya N Husain, Sydeaka Watson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 13, 2012
Optimization of response classification criteria for patients with malignant pleural mesothelioma
Zacariah E Labby, Samuel G Armato, Hedy L Kindler, et al.
Page
of 16